Ma, Jacques http://orcid.org/0000-0002-0547-3179
Cooper, Mark E. http://orcid.org/0000-0002-5953-642X
Article History
First Online: 12 August 2021
Competing interests
: M.E.C. has previously reviewed grants and has been a member of honorary advisory boards for companies that manufacture GLP1 agonists and other glucose-lowering drugs, including AstraZeneca, Novo Nordisk, Boehringer Ingelheim, MSD, Novartis, Sanofi and Eli Lilly and Company. J.M. declares no competing interests.